Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1591 to 1600 of 2417

TitleReference numberPublishedLast updated
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young peopleTA300
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosisTA624
Pegunigalsidase alfa for treating Fabry diseaseTA915
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabineTA440
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Pembrolizumab for adjuvant treatment of renal cell carcinomaTA830
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanomaTA837
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancerTA851

Results per page

  1. 10
  2. 25
  3. 50
  4. All